SEC 13F Intelligence

Boxer Capital, LLC / MRTXEUR

Boxer Capital, LLC’s Mirati Therapeutics Inc Position

Does Boxer Capital, LLC own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 3.20M shares worth $188M in Q4 2023; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$188M
Q4 2023
Shares
3.20M
% of Portfolio
+9.37%
Quarters Held
21
position exited

Position History MRTXEUR

Reported value by quarter
Q4 ’18: $66MQ4 ’18Q1 ’19: $126MQ2 ’19: $177MQ3 ’19: $134MQ3 ’19Q4 ’19: $221MQ1 ’20: $136MQ2 ’20: $202MQ2 ’20Q3 ’20: $293MQ4 ’20: $388MQ1 ’21: $343MQ1 ’21Q2 ’21: $323MQ3 ’21: $354MQ4 ’21: $293MQ4 ’21Q1 ’22: $164MQ2 ’22: $134MQ3 ’22: $140MQ3 ’22Q4 ’22: $91MQ1 ’23: $74,360Q2 ’23: $72,260Q2 ’23Q3 ’23: $139MQ4 ’23: $188Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20233.20M$188M+9.37%
Q3 20233.20M$139M+7.42%
Q2 20232.00M$72,260+3.35%
Q1 20232.00M$74,360+3.65%
Q4 20222.00M$91M+4.78%
Q3 20222.00M$140M+7.86%
Q2 20222.00M$134M+8.50%
Q1 20222.00M$164M+8.45%
Q4 20212.00M$293M+11.39%
Q3 20212.00M$354M+12.36%
Q2 20212.00M$323M+11.40%
Q1 20212.00M$343M+11.62%
Q4 20201.77M$388M+12.47%
Q3 20201.77M$293M+10.13%
Q2 20201.77M$202M+8.86%
Q1 20201.77M$136M+9.25%
Q4 20191.72M$221M+12.50%
Q3 20191.72M$134M+9.69%
Q2 20191.72M$177M+15.19%
Q1 20191.72M$126M+14.54%
Q4 20181.57M$66M+8.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of MRTXEUR.